Ultrasensitive C-reactive protein is generally used as an aid in the diagnosis of infectious diseases in newborns and as a risk indicator for cardiovascular disease. Ultrasensitive C-Reactive Protein 108 mostly indicates the presence of bacterial or viral infections in neonates, and the risk of atherosclerosis and acute cerebral infarction in adults.
1. Due to the incomplete development of liver and immune system, bacterial infection in newborns tends to develop very quickly, and only ultra-sensitive C-reactive protein can meet the needs of bacterial infection diagnosis in newborns, so ultra-sensitive C-reactive protein 108 mostly suggests that there is a possibility of infection in newborns.
2. Cardiovascular disease: clinical classification of cardiovascular disease risk for patients according to the level of ultrasensitive C-reactive protein: i.e., <1mg/L is relatively low risk, 1.0~3.0mg/L is medium risk, >3.0mg/L is high risk, and ultrasensitive C-reactive protein 108 suggests that the patients have cardiovascular and cerebrovascular risks such as atherosclerosis and acute cerebral infarction.
If there is an elevated ultra-sensitive c-reactive protein, you need to go to the hospital as soon as possible, by the doctor according to the specific conditions, to develop individualized diagnosis and treatment plan, so as not to delay the condition.